development. The SEC urged TIA to consider the possibility to become independent investment advisory institute supporting Thai capital market development. The institute could be a center for investor education
business operations, which could have a material impact on the company’s business. Therefore, ALL was required to disclose information regarding these legal disputes in the form 56-1 One Report for the year
the form 56-1 One Report for the year 2022. Specifically, ALL had two significant legal disputes related to its financial status and business operations, which could have a material impact on the
market price. As director and executive of the company at the time, Kitti disclosed such insider information to Kongpat, his nephew-in-law, even though he knew or should have known that Kongpat could
market price. As director and executive of the company at the time, Kitti disclosed such insider information to Kongpat, his nephew-in-law, even though he knew or should have known that Kongpat could
as he stated. Furthermore, in early August 2021, Dr. Boon still confirmed that the vaccines would be import within August 2021 but later he admitted that such vaccines could not be imported as he
or showed prices and trading volumes that is not actually occur during 2021 - 2022. Such information disclosure could mislead investors about the actual trading volumes or prices. This case is in the
in fact the machines could not be found. This case is in the process of inquiry by the special case inquiry official. SEC Act S.307 308 311 312 and section 352 353 and 354 of Penal Code in
acceptance of the machines and approved the full payment by IEC where in fact the machines could not be found. Prosecutorial stage issue a non-prosecution order. SEC Act S.307 308 311 312 and section 352
the machines and approved the full payment by IEC where in fact the machines could not be found. Prosecutorial stage issue a non-prosecution order. SEC Act S.307 308 311 312 in conjunction with 315